• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Unichem Laboratories Ltd

+ Add to Watchlist

UL:IN

222.95 INR 1.40 0.63%

As of 05:59:55 ET on 04/21/2014.

Snapshot for Unichem Laboratories Ltd (UL)

Open: 220.50 Day's Range: 214.75 - 225.35 Volume: 35,367
Previous Close: 221.55 52wk Range: 136.50 - 237.90 1-Yr Rtn: +36.47%

Stock Chart for UL

No chart data available.
  • UL:IN 223.40
  • 1D
  • 1M
  • 1Y
221.55
Interactive UL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for UL

Current P/E Ratio (ttm) 17.8421
Estimated P/E(03/2014) 15.5530
Relative P/E vs. SENSEX 1.0183
Earnings Per Share (INR) (ttm) 12.5237
Est. EPS (INR) (03/2014) 14.3670
Est. PEG Ratio -
Market Cap (M INR) 20,250.68
Shares Outstanding (M) 90.63
30 Day Average Volume 114,544
Price/Book (mrq) 2.7738
Price/Sale (ttm) 1.8650
Dividend Indicated Gross Yield 1.79%
Cash Dividend (INR) 4.0000
Dividend Ex-Date 01/23/2014
5 Year Dividend Growth 28.78%
Next Earnings Announcement 05/09/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for UL

No data available

Company Profile & Key Executives for UL

Unichem Laboratories Limited manufactures pharmaceutical drug formulations, bulk drugs and veterinary products. The Company's pharmaceutical products include anti-infectives, pain killers, cardiology drugs, psychiatry drugs, hormone supplements, gastro-intestinal drugs, diabetes drugs and nutritional products.

Prakash Amrut ModyChairman/Managing DirectorRakesh ParikhVP:Finance
K SubharamanVP:Legal/Secretary
More Company Profile & Key Executives for UL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil